Mechanism of microRNA-152-3p-Mediated Regulation of Autophagy and Sensitivity in Paclitaxel-Resistant Ovarian Cancer

Di Wu1, Yang Zhang1, Luna Zhang1

  • 1Department of Pharmacy, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116027, People's Republic of China.

Oncotargets and Therapy
|February 10, 2025
PubMed
Abstract

Insights

microRNA-152-3p downregulation reverses paclitaxel resistance in ovarian cancer by inhibiting autophagy and downregulating PTEN. This suggests PTEN as a therapeutic target for paclitaxel-resistant ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ovarian cancer remains a leading cause of cancer-related mortality.
  • Paclitaxel resistance is a major clinical challenge in ovarian cancer treatment.
  • MicroRNAs play crucial roles in cancer progression and drug resistance.

Purpose of the Study:

  • To investigate the role of microRNA-152-3p in paclitaxel-resistant ovarian cancer cells.
  • To elucidate the underlying mechanisms, including autophagy and PTEN regulation.
  • To explore the therapeutic potential of targeting miR-152-3p or its downstream effectors.

Main Methods:

  • Transfection of miR-152-3p mimics and inhibitors in ovarian cancer cell lines (A2780 and A2780T).
  • Quantitative PCR (qPCR) to assess miRNA and mRNA expression levels.
  • MTT assays to evaluate cell proliferation and drug sensitivity (IC50).
  • Western blotting to detect protein expression of PTEN and ATG4D.

Main Results:

  • miR-152-3p expression was significantly higher in paclitaxel-resistant cells (A2780T) compared to sensitive cells (A2780).
  • Downregulation of miR-152-3p reversed paclitaxel-induced autophagy, inhibited cell proliferation, promoted apoptosis, and reduced drug resistance.
  • Phosphatase and tensin homolog (PTEN) was identified as a direct target of miR-152-3p, and its downregulation by miR-152-3p was crucial for sensitizing cells to paclitaxel.

Conclusions:

  • miR-152-3p plays a critical role in modulating autophagy and paclitaxel sensitivity in ovarian cancer.
  • PTEN is a key mediator of miR-152-3p's effects on paclitaxel resistance.
  • PTEN represents a promising therapeutic target for overcoming paclitaxel resistance in ovarian cancer, offering a potential translational strategy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K